FTC Blasts Illumina's 'Conspiracy Theory' Over Grail Deal
Federal Trade Commission staffers pushed back against Illumina's contentions that enforcers improperly coordinated with overseas counterparts to try to derail its deal for cancer-testing outfit Grail Inc., saying the company wants...To view the full article, register now.
Already a subscriber? Click here to view full article